PGC and prostate cancer: PGC expression levels were apparently promoted, especially in the tumour, for example, in prostate cancer, breast cancer, ovary cancer, endometrial cancer, pancreatic cancer, kidney cancer, bladder cancer, eyelid basal cell carcinoma, squamous cell carcinoma and melanoma, etc. [5, 7, 8, 47–50].